Clinical Trials Logo
  1. Home
  2. Metformin
  3. NCT00942123

Study On the Role of Mitochondrial Dysfunction in the Pathogenesis of Metformin-associated Lactic Acidosis

Metformin Clinical Trial

Official title:
On the Role of Mitochondrial Dysfunction in the Pathogenesis of Metformin-associated Lactic Acidosis

Clinical Trial Summary

Metformin is the first line drug of choice for the treatment of type II diabetes. Lactic acidosis can develop as a side effect, especially when renal failure leads to drug accumulation. Lactic acidosis is usually attributed to an abnormal inhibition of hepatic lactate clearance.

Growing evidence suggest that metformin can dose-dependently inhibit hepatocyte mitochondrial function. Whether a similar effect occurs in extra-hepatic human tissues remains unknown.

The investigators hypothesize that mitochondrial dysfunction occurs during metformin intoxication even in tissues other than the liver, thus contributing to the development of lactic acidosis. The aim of this study is to investigate mitochondrial integrity in circulating platelets of patients with lactic acidosis due to metformin intoxication.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00942123
Study type Observational
Source Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Contact
Status Completed
Phase N/A
Start date January 2009
Completion date October 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05052918 - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes N/A
Recruiting NCT05469659 - Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Phase 2
Completed NCT00767351 - Variation in Serum Levels of Metformin in Patients With Reduced Renal Function
Recruiting NCT06126029 - Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients. Phase 2
Enrolling by invitation NCT05900284 - Safety and Feasibility of Metformin for Sepsis Induced AKI Phase 2
Enrolling by invitation NCT06125587 - Chiglitazar/Metformin in Non-obese Women With PCOS Phase 2/Phase 3
Not yet recruiting NCT05013112 - Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT) N/A
Recruiting NCT03525028 - A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis N/A
Recruiting NCT05680805 - Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS Phase 4
Not yet recruiting NCT05532813 - Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease) Phase 3
Recruiting NCT06325956 - PCOS Immune Function Predicts Metformin Efficacy N/A
Recruiting NCT06325969 - PCOS Patients Immune Status Evaluation
Completed NCT03335423 - Inter- and Intra-individual Variations in Metformin Pharmacokinetics - The Importance of Genes and Drug Interactions Phase 1
Recruiting NCT04477590 - Interactions of Medicine and Exercise With Meal Timing N/A
Not yet recruiting NCT06459310 - Pilot Study on Evaluating the Geroprotective Effect of Metformin Phase 2
Not yet recruiting NCT05412056 - Metformin to Prevent Preterm Birth in Twin Pregnancy Phase 2/Phase 3
Terminated NCT01756105 - Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women Phase 2
Completed NCT04377451 - Metformin in Dengue With Obesity Phase 1/Phase 2
Completed NCT03618472 - Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer Cells N/A
Recruiting NCT04581447 - Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care Phase 3